Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PRLD
#2987
Prelude Therapeutics Incorporated
2.7
6
-5.80%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-5.80%
Monatliche Änderung
+28.37%
6 month change
+113.95%
Jahresänderung
+253.85%
Vorheriger Schlusskurs
2.9
3
Open
2.7
6
Bid
Ask
Low
2.7
6
High
2.7
6
Volumen
3
Märkte
Aktien
Gesundheitswesen
PRLD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
42.18 M
42.3 M
43.6 M
43.74 M
43.75 M
173.4 M
Valuation ratios
Enterprise value
102.79 M
57.85 M
3.09 M
20.06 M
42.99 M
124 M
Price to earnings ratio
-1.18
-0.76
-0.46
-0.5
-0.99
-2.7
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-1.4
-0.94
-0.55
-0.57
-1.09
-3.15
Price to book ratio
0.19
0.74
0.1
0.13
0.3
1.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.16
0.23
0.27
0.21
0.87
Return on equity %
0.21
0.22
0.31
0.41
0.34
1.28
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
—
—
—
100
—
Operating margin %
1 145.87
—
—
—
314.12
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 075.7
—
—
—
303.46
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.04
5.3
5.18
3.68
3.21
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
—
—
—
0.06
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.36
0.27
0.45
0.34
0.25
1.32
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.03
1.76
1.3
0.96
0.72
4.75
Net current asset value per share
2.06
1.79
1.35
1.01
0.77
4.92
Tangible book value per share
2.06
1.73
1.36
1
0.77
4.86
Working capital per share
1.77
1.45
1.09
0.74
0.53
3.81
Book value per share
2.06
1.73
1.36
1
0.77
4.86
Nachrichten
Prelude Therapeutics: Citizens bestätigt "Market Outperform" und Kursziel von 3,00 $
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Prelude Therapeutics: Aktie legt nach FDA-Zulassung für Krebsmedikament deutlich zu
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Prelude Therapeutics: Citizens bestätigt ’Market Outperform’-Rating
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Incyte: Leiter des Rechnungswesens verkauft Aktien im Wert von 79.000 $
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Incyte-Aktie erreicht 52-Wochen-Hoch von 108,81 USD
Prelude Therapeutics übertrifft im dritten Quartal die Gewinnerwartungen – Aktie zeigt sich stabil